Gland Pharma Limited — QIP/Rights/Pref., 26-02-2025: Allotment of Securities

Gland Pharma has announced a board meeting to allot 4,700 equity shares at an exercise price of ₹542 each, fully paid up, under the Employee Stock Options Scheme, 2019. This allotment increases the company's paid-up share capital to ₹164.76 crore, now comprising 164,756,423 equity shares of face value ₹1 each. The total issued share capital post-allotment stands at ₹164.76 crore. The newly issued shares are identical in all respects to existing shares.